Conclusion
SPRINT is a pilot rehabilitation program that provides inpatient
intensive therapies for pediatric patients with hematologic and
oncologic diagnoses with significant functional deficits while
hospitalized for acute medical care. For patients who cannot safely
transition to inpatient rehabilitation due to acute medical issues,
participation in SPRINT can result in significant functional gains.
Despite therapy participation barriers mostly related to patient
complaints and symptoms, participation in SPRINT is generally safe with
no adverse events associated with the program. No significant difference
in the levels of patients’ tiredness, sadness, nervousness, or pain
between the start and end of SPRINT was detected on parent and self
report.
Future directions of this study include ongoing data collection of
additional SPRINT participants and potential subgroup analyses to
characterize factors associated with functional outcomes. Utilization of
a validated measure of subjective symptoms of children and adolescents
with oncologic and hematologic diagnoses will also be considered.